ILD Registry to deliver local and global benefit

The Australasian ILD Registry (AILDR), a bi-national registry of patients with all ILD subtypes, has the potential to address major research questions including around new therapeutics and biomarkers of disease. A pilot phase of the Registry, based at just four sites in Australia and comprising 1,061 patients, has just reported baseline data. Participants were mostly ...

Already a member?

Login to keep reading.

© 2022 the limbic